Jeanne Eagels

DMC ALERT: Bragar Eagel & Squire, P.C. Is Investigating DMC Global Inc. on Behalf of DMC Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, November 9, 2023

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against DMC Global Inc. (“DMC” or the “Company”) (NASDAQ: BOOM) on behalf of DMC stockholders.

Key Points: 
  • Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against DMC Global Inc. (“DMC” or the “Company”) (NASDAQ: BOOM) on behalf of DMC stockholders.
  • Our investigation concerns whether DMC has violated the federal securities laws and/or engaged in other unlawful business practices.
  • After the market closed on November 2, 2023, DMC reported its financial results for the third quarter of 2023.
  • Among other things, DMC reported a Non-GAAP EPS of $0.50, missing consensus estimates by $0.08, and a revenue figure of $172.1 million, missing consensus estimates by $11.87 million.

HOLLEY ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Holley Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Wednesday, November 8, 2023

Investors have until January 5, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until January 5, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • On July 28, 2022, Holley announced preliminary financial results that missed expectations and slashed its full year 2022 outlook.
  • On this news, the price of Holley stock fell more than 47% over two trading sessions.
  • Then, on November 14, 2022, Holley further announced disappointing financial results for third quarter 2022.

BLUE RIDGE ALERT: Bragar Eagel & Squire, P.C. is Investigating Blue Ridge Bankshares, Inc. on Behalf of Blue Ridge Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, November 6, 2023

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Blue Ridge Bankshares, Inc. (“Blue Ridge” or the “Company”) (NYSE American: BRBS) on behalf of Blue Ridge stockholders.

Key Points: 
  • Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Blue Ridge Bankshares, Inc. (“Blue Ridge” or the “Company”) (NYSE American: BRBS) on behalf of Blue Ridge stockholders.
  • Our investigation concerns whether Blue Ridge has violated the federal securities laws and/or engaged in other unlawful business practices.
  • Click here to participate in the action.
  • On this news, Blue Ridge's stock price fell $1.06 per share, or 33.65%, to close at $2.09 per share on November 1, 2023.

PAYCOM ALERT: Bragar Eagel & Squire, P.C. is Investigating Paycom Software, Inc. on Behalf of Paycom Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, November 6, 2023

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Paycom Software, Inc. (“Paycom” or the “Company”) (NYSE: PAYC) on behalf of Paycom stockholders.

Key Points: 
  • Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Paycom Software, Inc. (“Paycom” or the “Company”) (NYSE: PAYC) on behalf of Paycom stockholders.
  • Our investigation concerns whether Paycom has violated the federal securities laws and/or engaged in other unlawful business practices.
  • As a result, customers have stopped purchasing Paycom’s other services and billable items, which has affected the Company’s revenues.
  • On this news, the price of Paycom shares declined by $94.28, or approximately 38.49%, from $244.97 per share to $150.69 on November 1, 2023.

LESLIE’S DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Leslie’s, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, November 4, 2023

Investors have until November 7, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until November 7, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Click here to participate in the action.
  • Leslie’s common stock price continued to fall another $1.24 per share the following trading day, or over 18%, closing at $5.46 per share on July 17, 2023.
  • There is no cost or obligation to you.

BRAINSTORM CELL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Brainstorm Cell Therapeutics Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, November 4, 2023

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Brainstorm Cell Therapeutics Inc. (“Brainstorm Cell” or the “Company”) (NASDAQ: BCLI) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired Brainstorm Cell securities between August 15, 2022 and September 27, 2023, both dates inclusive (the “Class Period”).

Key Points: 
  • Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Brainstorm Cell Therapeutics Inc. (“Brainstorm Cell” or the “Company”) (NASDAQ: BCLI) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired Brainstorm Cell securities between August 15, 2022 and September 27, 2023, both dates inclusive (the “Class Period”).
  • Investors have until January 2, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Click here to participate in the action.
  • There is no cost or obligation to you.

SPERO ALERT: Bragar Eagel & Squire, P.C. is Investigating Spero Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Friday, November 3, 2023

Our investigation concerns whether the board of directors of Spero have breached their fiduciary duties to the company.

Key Points: 
  • Our investigation concerns whether the board of directors of Spero have breached their fiduciary duties to the company.
  • Spero, a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant bacterial infections and rare diseases in the United States.
  • The Company's product candidates include Tebipenem Pivoxil Hydrobromide (HBr), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adults.
  • On March 31, 2022, Spero issued a press release announcing the Company’s fourth quarter and full year 2021 financial results.

VIRTU ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Virtu Financial, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, November 2, 2023

Investors have until January 2, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until January 2, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • According to the Complaint, the Company made false and misleading statements to the market.
  • Virtu maintained a generic username and password that allowed its employees including proprietary traders to access the confidential trading information of customers.
  • Based on these facts, the Company's public statements were false and materially misleading throughout the class period.

DFS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Discover Financial Services and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, October 28, 2023

Investors have until October 30, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until October 30, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • According to the complaint, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and compliance policies.
  • On July 20, 2022, DFS issued a press release announcing its financial results for the second quarter of 2022.
  • On July 19, 2023, DFS issued a press release announcing its financial results for the second quarter of 2023.

NAPCO DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against NAPCO Security Technologies, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, October 28, 2023

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against NAPCO Security Technologies, Inc. (“NAPCO” or the “Company”) (NASDAQ: NSSC) in the United States District Court for the Eastern District of New York on behalf of all persons and entities who purchased or otherwise acquired NAPCO securities between November 7, 2022 and August 18, 2023, both dates inclusive (the “Class Period”).

Key Points: 
  • Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against NAPCO Security Technologies, Inc. (“NAPCO” or the “Company”) (NASDAQ: NSSC) in the United States District Court for the Eastern District of New York on behalf of all persons and entities who purchased or otherwise acquired NAPCO securities between November 7, 2022 and August 18, 2023, both dates inclusive (the “Class Period”).
  • Investors have until October 30, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Click here to participate in the action.
  • There is no cost or obligation to you.